FactSet stock hits 52-week low at 282.0 USD

FactSet (FDS) stock recently reached a 52-week low of $282.0, reflecting a 38.17% decline over the past year and an oversold RSI, primarily driven by weaker-than-expected fiscal Q4 results and disappointing 2026 guidance. Despite solid fundamentals, including revenue growth and a strong dividend track record, the market's reaction underscores broader concerns within the financial services industry. Analyst sentiment is mixed, with UBS upgrading FactSet to Buy on AI integration potential, while Goldman Sachs maintained a Sell rating, indicating a divided outlook on the company's future performance and valuation.

Analysis

FactSet Research Systems (FDS) has reached a 52-week low of $282.0, marking a significant 38.17% decline over the past year. The negative momentum is primarily driven by disappointing fiscal fourth-quarter results, which featured weaker-than-expected organic revenue growth, operating margins, and earnings per share. This underperformance was exacerbated by new fiscal 2026 guidance that fell short of market expectations on both top and bottom lines. Specific pressures on margins were attributed by BMO Capital to higher technology expenses and increased bonus payments. Despite these headwinds, the company maintains some solid fundamentals, including a P/E ratio of 18.2, reported revenue growth of 5.39%, and a strong dividend history. Technical indicators suggest the stock is in oversold territory according to its RSI. Analyst sentiment is sharply divided, reflecting the uncertainty surrounding the company's trajectory. UBS upgraded the stock to 'Buy' with a $425 price target, citing long-term potential from AI integration, while Goldman Sachs maintained a 'Sell' rating, lowering its target to the recent low of $282. Other analysts like Stifel and BMO hold more neutral positions with price targets of $372 and $324, respectively, highlighting a clear divergence between near-term operational challenges and potential long-term strategic value.

Key Decisions for Investors

• Given the weak Q4 results and disappointing forward guidance, risk-averse investors should monitor for evidence of margin stabilization and a recovery in organic growth before considering a new position.
• For long-term, value-oriented investors, the stock's oversold status, coupled with ongoing revenue growth and a potential catalyst in AI integration, may present a contrarian buying opportunity, aligning with the more bullish analyst outlooks.
• The wide dispersion in analyst price targets from $282 to $425 underscores significant uncertainty, suggesting that any position should be sized appropriately to account for potential volatility and the risk of further near-term underperformance.